Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05310591
Title Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence (CAPTiRALL)
Acronym CAPTiRALL
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Assistance Publique - Hôpitaux de Paris
Indications
Therapies
Age Groups: adult | child
Covered Countries FRA

Facility Status City State Zip Country Details
CHRU Bordeaux RECRUITING Bordeaux France Details
CHRU Lille RECRUITING Lille France Details
HCL - Lyon Sud RECRUITING Lyon France Details
HCL RECRUITING Lyon France Details
HCL RECRUITING Lyon France Details
Hôpital pour enfants - La Timone RECRUITING Marseille France Details
CHU Montpellier - Hopital Arnaud de Villeneuve RECRUITING Montpellier France Details
CHU Nancy RECRUITING Nancy France Details
CHU Nantes - Hopital Mère-enfants RECRUITING Nantes France Details
Robert Debre hospital RECRUITING Paris France Details
Saint Louis hospital RECRUITING Paris France Details
CHU Rouen RECRUITING Rouen France Details
CHRU Strasbourg RECRUITING Strasbourg France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field